LOS ANGELES, CA / ACCESSWIRE / September 27, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Xylem Inc. ("Xylem" or "the Company") (NYSE:XYL) who were Evoqua (NYSE:AQUA) shareholders who received shares of Xylem, Inc. through the 2023 merger for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Xylem is the subject of a report published by Spruce Point Capital Management on August 9, 2023. The report includes "concerns about the accuracy of the Company's cash liquidity given findings of two sets of financial statements and its ability to meet Wall Street's aggressive financial expectations." According to the report, the Company's merger with Evoqua "is predicated primarily on $140 million of cost savings synergies, and despite dangling a carrot of potential revenue synergies, Xylem has not offered any quantitative assessment of the opportunities."
If you are a former Evoqua shareholder who received Xylem stock in the 2023 merger, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at [email protected].
The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
SOURCE: The Schall Law Firm